Huaota Biopharm

company

About

Huaota Biopharm develops high-quality biological drugs for the global market.

  • 251 - 500

Details

Last Funding Type
Angel
Last Funding Money Raised
¥3M
Industries
Biopharma,Biotechnology,Health Care,Manufacturing,Medical
Founded date
Sep 10, 2013
Number Of Employee
251 - 500
Operating Status
Active

Shanghai Huaota Biopharm is a wholly owned subsidiary of Huahai Pharmaceuticals and was established in September 2013. Huaota is dedicated to develop high quality biological drugs for global market to meet the demand of availability and affordability for high-end biological products from global patients. Huaota employs the state-of-the-art biopharmaceutical manufacturing technology and equipments to build production line meeting the GMP requirement from CFDA, US FDA and EU EMA. Huaota currently has one 200L and one 1000L disposable bioreactor and two fill-and-finish lines to support both prefilled syringe and vial filling.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥3M
Huaota Biopharm has raised a total of ¥3M in funding over 2 rounds. Their latest funding was raised on Oct 30, 2017 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 30, 2017 Angel ¥3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Huaota Biopharm is funded by 1 investors. Huahai Yaoye are the most recent investors.
Investor Name Lead Investor Funding Round
Huahai Yaoye Angel